128 related articles for article (PubMed ID: 7885391)
21. Increasing rates of DNA single-strand breaks in lymphocytes of clinical personnel handling cytostatic drugs.
Reitz M; Afghanyar S; Gutjahr P
J Cancer Res Clin Oncol; 1993; 119(4):237-42. PubMed ID: 8423200
[TBL] [Abstract][Full Text] [Related]
22. Chromosomal aberrations and micronucleus frequency in nurses occupationally exposed to cytotoxic drugs.
Anwar WA; Salama SI; el Serafy MM; Hemida SA; Hafez AS
Mutagenesis; 1994 Jul; 9(4):315-7. PubMed ID: 7968572
[TBL] [Abstract][Full Text] [Related]
23. DNA strand breaks and DNA cross-links in peripheral mononuclear blood cells of ovarian cancer patients during chemotherapy with cyclophosphamide/carboplatin.
Hengstler JG; Fuchs J; Oesch F
Cancer Res; 1992 Oct; 52(20):5622-6. PubMed ID: 1394186
[TBL] [Abstract][Full Text] [Related]
24. Predictors of adherence to safe handling practices for antineoplastic drugs: A survey of hospital nurses.
Silver SR; Steege AL; Boiano JM
J Occup Environ Hyg; 2016; 13(3):203-12. PubMed ID: 26556549
[TBL] [Abstract][Full Text] [Related]
25. Genotoxicity of environmental agents assessed by the alkaline comet assay.
Møller P
Basic Clin Pharmacol Toxicol; 2005; 96 Suppl 1():1-42. PubMed ID: 15859009
[TBL] [Abstract][Full Text] [Related]
26. Urinary cyclophosphamide excretion and micronuclei frequencies in peripheral lymphocytes and in exfoliated buccal epithelial cells of nurses handling antineoplastics.
Burgaz S; Karahalil B; Bayrak P; Taşkin L; Yavuzaslan F; Bökesoy I; Anzion RB; Bos RP; Platin N
Mutat Res; 1999 Feb; 439(1):97-104. PubMed ID: 10029685
[TBL] [Abstract][Full Text] [Related]
27. DNA single strand break analysis in mononuclear blood cells of petrol pump attendants.
Oesch F; Fuchs J; Vaupel J; Hengstler JG
Int Arch Occup Environ Health; 1995; 67(1):35-9. PubMed ID: 7622277
[TBL] [Abstract][Full Text] [Related]
28. Cigarette smoking protects mononuclear blood cells of carcinogen exposed workers from additional work exposure-induced DNA single strand breaks.
Oesch F; Hengstler JG; Fuchs J
Mutat Res; 1994 May; 321(3):175-85. PubMed ID: 7513068
[TBL] [Abstract][Full Text] [Related]
29. Genotoxic risks to nurses from contamination of the work environment with antineoplastic drugs in Japan.
Yoshida J; Kosaka H; Tomioka K; Kumagai S
J Occup Health; 2006 Nov; 48(6):517-22. PubMed ID: 17179646
[TBL] [Abstract][Full Text] [Related]
30. Comparison of methods for the biomonitoring of nurses handling antitumor drugs.
Thiringer G; Granung G; Holmén A; Högstedt B; Järvholm B; Jönsson D; Persson L; Wahlström J; Westin J
Scand J Work Environ Health; 1991 Apr; 17(2):133-8. PubMed ID: 2047815
[TBL] [Abstract][Full Text] [Related]
31. [Genotoxic risk assessment of nurses handling antineoplastic drugs].
Boughattas AB; Bouraoui S; Debbabi F; El Ghazel H; Saad A; Mrizak N
Ann Biol Clin (Paris); 2010; 68(5):545-53. PubMed ID: 20870576
[TBL] [Abstract][Full Text] [Related]
32. Assessment of DNA damage in WBCs of workers occupationally exposed to fumes and aerosols of bitumen.
Marczynski B; Raulf-Heimsoth M; Preuss R; Kappler M; Schott K; Pesch B; Zoubek G; Hahn JU; Mensing T; Angerer J; Käfferlein HU; Brüning T
Cancer Epidemiol Biomarkers Prev; 2006 Apr; 15(4):645-51. PubMed ID: 16614104
[TBL] [Abstract][Full Text] [Related]
33. Application of the alkaline comet assay in human biomonitoring for genotoxicity: a study on Croatian medical personnel handling antineoplastic drugs.
Kopjar N; Garaj-Vrhovac V
Mutagenesis; 2001 Jan; 16(1):71-8. PubMed ID: 11139601
[TBL] [Abstract][Full Text] [Related]
34. Cytogenetic consequences after occupational exposure to antineoplastic drugs.
Fucic A; Jazbec A; Mijic A; Seso-Simic D; Tomek R
Mutat Res; 1998 Aug; 416(1-2):59-66. PubMed ID: 9725992
[TBL] [Abstract][Full Text] [Related]
35. Biomonitoring of DNA damage by alkaline filter elution.
Doerjer G; Buchholz U; Kreuzer K; Oesch F
Int Arch Occup Environ Health; 1988; 60(3):169-74. PubMed ID: 3384482
[TBL] [Abstract][Full Text] [Related]
36. Applicability of the comet assay in evaluation of DNA damage in healthcare providers' working with antineoplastic drugs: a systematic review and meta-analysis.
Zare Sakhvidi MJ; Hajaghazadeh M; Mostaghaci M; Mehrparvar AH; Zare Sakhvidi F; Naghshineh E
Int J Occup Environ Health; 2016 Jan; 22(1):52-67. PubMed ID: 27110842
[TBL] [Abstract][Full Text] [Related]
37. Assessment of chromosomal aberrations, micronuclei and proliferation rate index in peripheral lymphocytes from Tunisian nurses handling cytotoxic drugs.
Bouraoui S; Brahem A; Tabka F; Mrizek N; Saad A; Elghezal H
Environ Toxicol Pharmacol; 2011 Jan; 31(1):250-7. PubMed ID: 21787692
[TBL] [Abstract][Full Text] [Related]
38. Assessment of genotoxic damage in nurses occupationally exposed to antineoplastics by the analysis of chromosomal aberrations.
Burgaz S; Karahalil B; Canhi Z; Terzioglu F; Ançel G; Anzion RB; Bos RP; Hüttner E
Hum Exp Toxicol; 2002 Mar; 21(3):129-35. PubMed ID: 12102538
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal biomonitoring of nurses handling antineoplastic drugs.
Mader RM; Kokalj A; Kratochvil E; Pilger A; Rüdiger HW
J Clin Nurs; 2009 Jan; 18(2):263-9. PubMed ID: 18624785
[TBL] [Abstract][Full Text] [Related]
40. Effects of organizational safety practices and perceived safety climate on PPE usage, engineering controls, and adverse events involving liquid antineoplastic drugs among nurses.
DeJoy DM; Smith TD; Woldu H; Dyal MA; Steege AL; Boiano JM
J Occup Environ Hyg; 2017 Jul; 14(7):485-493. PubMed ID: 28326998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
